Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

chiesi pharmaceuticals gmbh, rakúsko - formoterol a beklometazón - 14 - bronchodilatantia, antiasthmatica

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

chiesi pharmaceuticals gmbh, rakúsko - formoterol a beklometazón - 14 - bronchodilatantia, antiasthmatica

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

chiesi pharmaceuticals gmbh, rakúsko - formoterol a beklometazón - 14 - bronchodilatantia, antiasthmatica

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

chiesi pharmaceuticals gmbh, rakúsko - formoterol a beklometazón - 14 - bronchodilatantia, antiasthmatica

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

chiesi pharmaceuticals gmbh, rakúsko - formoterol a beklometazón - 14 - bronchodilatantia, antiasthmatica

Európska únia - slovenčina - EMA (European Medicines Agency)

glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - herpes zoster - vakcíny - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. použitie shingrix by mali byť v súlade s oficiálne odporúčania.

Európska únia - slovenčina - EMA (European Medicines Agency)

merck sharp & dohme b.v. - vírus varicella-zoster (živý, zoslabený) - herpes zoster; immunization - vírusové vakcíny - zostavax je indikovaný na prevenciu pásového oparu ("zoster" alebo šindle) a súvisiace s herpes zoster postherpetická neuralgia. zostavax je indikovaný na imunizácie jednotlivcov 50 rokov alebo starší.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

x-spine systems inc. 452 alexandersville road miamisburg, oh spojené štáty americké -

Európska únia - slovenčina - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Európska únia - slovenčina - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - upadacitinib - artritída, reumatoidná artritída - imunosupresíva - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.